{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T03:18:15Z","timestamp":1771557495942,"version":"3.50.1"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T00:00:00Z","timestamp":1532131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473029"],"award-info":[{"award-number":["81473029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703273"],"award-info":[{"award-number":["81703273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81502853"],"award-info":[{"award-number":["81502853"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473028"],"award-info":[{"award-number":["81473028"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["2016NJMUZD012"],"award-info":[{"award-number":["2016NJMUZD012"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20171054"],"award-info":[{"award-number":["BK20171054"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20151026"],"award-info":[{"award-number":["BK20151026"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,31]]},"DOI":"10.1093\/carcin\/bgy099","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T09:56:45Z","timestamp":1532080605000},"page":"1497-1505","source":"Crossref","is-referenced-by-count":26,"title":["The development of hepatocellular carcinoma in HCV-infected patients treated with DAA: A comprehensive analysis"],"prefix":"10.1093","volume":"39","author":[{"given":"Peng","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China"},{"name":"Key Laboratory of Infectious Diseases, School of Public Health, Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Zang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinan","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Basic and Community Nursing, School of Nursing, Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haozhi","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Zhuo","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueshan","family":"Xia","sequence":"additional","affiliation":[{"name":"Faculty of Life Science and Technology, Kunming University of Science and Technology, Chenggong District, Kunming, Yunnan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Feng","sequence":"additional","affiliation":[{"name":"Faculty of Life Science and Technology, Kunming University of Science and Technology, Chenggong District, Kunming, Yunnan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongbin","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China"},{"name":"Key Laboratory of Infectious Diseases, School of Public Health, Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,7,21]]},"reference":[{"key":"key\n\t\t\t\t2019010210590254500_CIT0001","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.27222","article-title":"Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go","volume":"60","author":"El-Serag","year":"2014","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0002","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000456580","article-title":"Lessons from epidemiology: the burden of liver disease","volume":"35","author":"Rowe","year":"2017","journal-title":"Dig. Dis"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0003","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1306218","article-title":"Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection","volume":"370","author":"Sulkowski","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0004","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.dld.2017.03.025","article-title":"HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: the ITAL-C network study","volume":"49","author":"Ippolito","year":"2017","journal-title":"Dig. Liver Dis"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0005","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0140-6736(95)91739-X","article-title":"Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis","volume":"346","author":"Nishiguchi","year":"1995","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0006","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cgh.2009.10.026","article-title":"Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis","volume":"8","author":"Singal","year":"2010","journal-title":"Clin. Gastroenterol. Hepatol"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0007","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.gastro.2008.09.014","article-title":"Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease","volume":"136","author":"Lok","year":"2009","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0008","doi-asserted-by":"crossref","DOI":"10.1002\/hep.28535","article-title":"Risk of hepatocellular carcinoma after sustained virologic response in veterans with HCV-infection","author":"El-Serag","year":"2016","journal-title":"Hepatology, 64, 130\u2013137"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0009","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-2036.2010.04414.x","article-title":"Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma","volume":"32","author":"Singal","year":"2010","journal-title":"Aliment. Pharmacol. Ther"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12876-017-0606-9","article-title":"Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis","volume":"17","author":"Bang","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0011","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ijc.30521","article-title":"Impact of sustained viral response postcurative therapy of hepatitis C-related hepatocellular carcinoma: a systematic review and meta-analysis","volume":"140","author":"Manthravadi","year":"2017","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0012","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jhep.2016.01.034","article-title":"Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population","volume":"64","author":"Bruno","year":"2016","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0013","volume-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses","author":"Wells","year":"2011"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0014","year":". (2014)"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Br. Med. J"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0016","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2016.06.015","article-title":"Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals","volume":"65","author":"Conti","year":"2016","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0017","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jhep.2016.06.019","article-title":"Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis","volume":"65","author":"Cheung","year":"2016","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0018","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jmv.24663","article-title":"Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infection","volume":"89","author":"Kobayashi","year":"2017","journal-title":"J. Med. Virol"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0019","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jhep.2016.07.027","article-title":"High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis","volume":"65","author":"Cardoso","year":"2016","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0020","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jhep.2016.06.009","article-title":"Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment","volume":"65","author":"Kozbial","year":"2016","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0021","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jhep.2016.07.029","article-title":"Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: too alarming","volume":"65","author":"Zeng","year":"2016","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0022","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents","volume":"153","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0023","article-title":"Impact of sustained virologic response with direct\u2010acting antiviral treatment on mortality in patients with advanced liver disease","author":"Backus","year":"2017","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0024","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1053\/j.gastro.2016.12.021","article-title":"Unusually high rates of hepatocellular carcinoma after treatment with direct-acting antiviral therapy for hepatitis C related cirrhosis","volume":"152","author":"Ravi","year":"2017","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0025","article-title":"HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma","author":"Ioannou","year":"2017","journal-title":"J. Hepatol, 68, 25\u201332"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0026","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jhep.2016.05.045","article-title":"Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: data from three ANRS cohorts","volume":"65","author":"ANRS Collaborative Study Group on Hepatocellular Carcinoma (ANRS CO22 HEPATHER, CO12 CirVir and CO23 CUPILT Cohorts)","year":"2016","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0027","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","article-title":"Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy","volume":"65","author":"Reig","year":"2016","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0028","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/liv.13456","article-title":"Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C","volume":"37","author":"Virlogeux","year":"2017","journal-title":"Liver Int"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0029","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2016.05.034","article-title":"Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals: first, do no harm by withdrawing treatment","volume":"65","author":"Torres","year":"2016","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0030","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2016.06.023","article-title":"Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma","volume":"65","author":"Yang","year":"2016","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0031","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jhep.2016.08.016","article-title":"Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured","volume":"66","author":"Zavaglia","year":"2017","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0032","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El\u2013Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0033","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jhep.2009.12.041","article-title":"Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach","volume":"52","author":"Shen","year":"2010","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0034","doi-asserted-by":"crossref","DOI":"10.1111\/liv.13071","article-title":"Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis","author":"Tada","year":"2016","journal-title":"Liver Int, 36, 817\u2013826"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0035","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jhep.2015.06.003","article-title":"HCV targeting of patients with cirrhosis","volume":"63","author":"Ferenci","year":"2015","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0036","article-title":"HCV clearance by direct antiviral therapy and occurrence\/recurrence of hepatocellular carcinoma: a \u201ctrue-or-false game\u201d","author":"Russo","year":"2017","journal-title":"Elsevier, 49, 321\u2013325"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0037","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1476-4598-9-74","article-title":"Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma","volume":"9","author":"Tsuchiya","year":"2010","journal-title":"Mol. Cancer"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0038","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/hep.28848","article-title":"\u201cHep C, where art thou\u201d: what are the remaining (fundable) questions in hepatitis C virus research","volume":"65","author":"Rosen","year":"2017","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0039","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.gastro.2008.05.044","article-title":"Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C","volume":"135","author":"Maylin","year":"2008","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0040","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis","volume":"308","author":"van der Meer","year":"2012","journal-title":"J. Am. Med. Assoc"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0041","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-158-5-201303050-00005","article-title":"Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies","volume":"158","author":"Morgan","year":"2013","journal-title":"Ann. Intern. Med"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0042","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis","volume":"308","author":"Aj","year":"2012","journal-title":"J. Am. Med. Assoc"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0043","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2014.03.012","article-title":"Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C","volume":"107","author":"Lee","year":"2014","journal-title":"Antiviral Res"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0044","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/apt.13821","article-title":"Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon","volume":"45","author":"Petta","year":"2017","journal-title":"Aliment. Pharmacol. Ther"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0045","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3892\/mco.2014.386","article-title":"Adjuvant interferon for early or late recurrence of hepatocellular carcinoma and mortality from hepatocellular carcinoma following curative treatment: a meta-analysis with comparison of different types of hepatitis","volume":"2","author":"Zhang","year":"2014","journal-title":"Mol. Clin. Oncol"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0046","first-page":"776","article-title":"The possible association between DAA treatment for HCV infection and HCC recurrence","volume":"12","author":"Jr","year":"2016","journal-title":"Gastroenterol. Hepatol"},{"key":"key\n\t\t\t\t2019010210590254500_CIT0047","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jhep.2016.07.004","article-title":"Hepatocellular carcinoma and direct acting antiviral treatments: controversy after the revolution","volume":"65","author":"Nault","year":"2016","journal-title":"J. Hepatol"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/39\/12\/1497\/27366040\/bgy099.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T22:46:56Z","timestamp":1571611616000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/39\/12\/1497\/5056923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,21]]},"references-count":47,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,7,21]]},"published-print":{"date-parts":[[2018,12,31]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgy099","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,7,21]]}}}